Are you looking for a reliable partner to support your bioequivalence trials?
Your generic or biosimilar project will be in best hands with us.
CRS is a leading European full-service contract research organisation (CRO). It offers a complete range of high-quality clinical development and consulting services to companies operating in pharmaceuticals, biotechnology, medical devices and alimentary supplementation. The key factors in CRS's success are its rigorous client focus, its valued reliability and flexibility, and its ability to meet the very highest expectations.
CRS's excellent track record is based on nearly four decades of experience in clinical research combined with a dedicated and highly motivated team. CRS provides its services as a fully integrated array as well as on a modular basis.
Find out why clients from pharmaceutical, biotech and medical device companies of all sizes choose to work with CRS as their CRO of choice.
Based on the CSR rating by EcoVadis in July 2016 CRS has been granted a Silver Recognition Level.
CRS is proud to be recognised by pharma companies worldwide as leading CRO with regard to: capabilities, compatibility, expertise, quality and reliability. Click here for more information.
Find CRS's company profile in the European Biotechnology Science & Industry Guide, volume 6 2016.
On 07 May 2014 CRS received the Stifterverband's Quality Seal "Innovative Through Research" for its particular engagement in research.